BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 32407951)

  • 1. Ubiquitin biology in neurodegenerative disorders: From impairment to therapeutic strategies.
    Kumar D; Ambasta RK; Kumar P
    Ageing Res Rev; 2020 Aug; 61():101078. PubMed ID: 32407951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.
    Huang Q; Figueiredo-Pereira ME
    Apoptosis; 2010 Nov; 15(11):1292-311. PubMed ID: 20131003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities.
    Schmidt MF; Gan ZY; Komander D; Dewson G
    Cell Death Differ; 2021 Feb; 28(2):570-590. PubMed ID: 33414510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?
    Dennissen FJ; Kholod N; van Leeuwen FW
    Prog Neurobiol; 2012 Feb; 96(2):190-207. PubMed ID: 22270043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system.
    Petrucelli L; Dawson TM
    Ann Med; 2004; 36(4):315-20. PubMed ID: 15224658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of ubiquitin proteasome system: risk for neurodegenerative diseases.
    Zheng C; Geetha T; Babu JR
    Neurodegener Dis; 2014; 14(4):161-75. PubMed ID: 25413678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ubiquitin-proteasome system in neurodegeneration.
    McKinnon C; Tabrizi SJ
    Antioxid Redox Signal; 2014 Dec; 21(17):2302-21. PubMed ID: 24437518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration.
    Deger JM; Gerson JE; Kayed R
    Aging Cell; 2015 Oct; 14(5):715-24. PubMed ID: 26053162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome Subunits Involved in Neurodegenerative Diseases.
    Fernández-Cruz I; Reynaud E
    Arch Med Res; 2021 Jan; 52(1):1-14. PubMed ID: 32962866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease.
    Gadhave K; Bolshette N; Ahire A; Pardeshi R; Thakur K; Trandafir C; Istrate A; Ahmed S; Lahkar M; Muresanu DF; Balea M
    J Cell Mol Med; 2016 Jul; 20(7):1392-407. PubMed ID: 27028664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg.
    Ciechanover A; Brundin P
    Neuron; 2003 Oct; 40(2):427-46. PubMed ID: 14556719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ubiquitin proteasome system as a potential therapeutic target for treatment of neurodegenerative diseases.
    Opattova A; Cente M; Novak M; Filipcik P
    Gen Physiol Biophys; 2015 Oct; 34(4):337-52. PubMed ID: 26221742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N; Tanaka K
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggregopathy in neurodegenerative diseases: mechanisms and therapeutic implication.
    Dohm CP; Kermer P; Bähr M
    Neurodegener Dis; 2008; 5(6):321-38. PubMed ID: 18309232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Role of Ubiquitin-Proteasome System in Parkinson's Disease.
    Behl T; Kumar S; Althafar ZM; Sehgal A; Singh S; Sharma N; Badavath VN; Yadav S; Bhatia S; Al-Harrasi A; Almoshari Y; Almikhlafi MA; Bungau S
    Mol Neurobiol; 2022 Jul; 59(7):4257-4273. PubMed ID: 35505049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein clearance strategies for disease intervention.
    Hommen F; Bilican S; Vilchez D
    J Neural Transm (Vienna); 2022 Feb; 129(2):141-172. PubMed ID: 34689261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ubiquitin System in Alzheimer's Disease.
    Harris LD; Jasem S; Licchesi JDF
    Adv Exp Med Biol; 2020; 1233():195-221. PubMed ID: 32274758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin proteasome system as a potential target for the treatment of neurodegenerative diseases.
    Ying Z; Wang H; Wang G
    Curr Pharm Des; 2013; 19(18):3305-14. PubMed ID: 23151138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.